Published in Cancer Weekly, October 14th, 2008
"Mammalian two-hybrid assay showed that arachidonic acid enhanced binding of one of the coactivators. p300, to PPAR alpha but not to PPAR delta. Additionally, arachidonic acid induced in vitro...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.